On the public citation graph
15 Years of Patient-Reported Outcomes in Clinical Trials Leading to Gu Cancer Drug Approvals: A Focus on the Quality of Data Reporting and Analysis
0 signed · 41 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.2013.879openalex-extracted
Reporting of Patient-Reported Outcomes in Randomized Trials
inferredcites →https://doi.org/10.1001/jama.2017.21903openalex-extracted
Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols
inferredcites →https://doi.org/10.1001/jamaoncol.2015.0530openalex-extracted
Patient-Reported Outcomes in Cancer Drug Development and US Regulatory Review
inferredcites →https://doi.org/10.1002/(issn)1542-4863openalex-extracted
CA A Cancer Journal for Clinicians
inferredcites →https://doi.org/10.1002/(sici)1097-0258(19980315/15)17:5/7<711::aid-sim816>3.0.co;2-hopenalex-extracted
Suggestions for the presentation of quality of life data from clinical trials
inferredcites →https://doi.org/10.1002/cncr.29489openalex-extracted
Quality of patient‐reported outcome reporting across cancer randomized controlled trials according to the CONSORT patient‐reported outcome extension: A pooled analysis of 557 trials
inferredcites →https://doi.org/10.1007/s11136-010-9793-3openalex-extracted
Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers
inferredcites →https://doi.org/10.1007/s11136-016-1339-xopenalex-extracted
The patient-reported outcome content of international ovarian cancer randomised controlled trial protocols
inferredcites →https://doi.org/10.1016/j.cct.2015.04.004openalex-extracted
Inclusion of patient-reported outcome measures in registered clinical trials: Evidence from ClinicalTrials.gov (2007–2013)
inferredcites →https://doi.org/10.1016/j.cct.2015.09.012openalex-extracted
What can we do about exploratory analyses in clinical trials?
inferredcites →https://doi.org/10.1016/j.clgc.2021.12.002openalex-extracted
Evaluation of Patient-Reported Outcomes (PROs) Protocol Content and Reporting for Clinical Trials that Lead to the approval of frontline Immune Checkpoint Blockade Combination for Patients with Advanced Renal Cell Carcinoma - The Patients’ Voice or a Missed Opportunity
inferredcites →https://doi.org/10.1016/j.conctc.2017.11.009openalex-extracted
The administration of patient-reported outcome questionnaires in cancer trials: Interviews with trial coordinators regarding their roles, experiences, challenges and training
inferredcites →https://doi.org/10.1016/j.ejca.2014.04.005openalex-extracted
Patient-reported outcomes in randomised controlled trials of gynaecological cancers: Investigating methodological quality and impact on clinical decision-making
inferredcites →https://doi.org/10.1016/j.ejca.2015.12.025openalex-extracted
Patient-reported outcomes in head and neck and thyroid cancer randomised controlled trials: A systematic review of completeness of reporting and impact on interpretation
inferredcites →https://doi.org/10.1016/j.euf.2019.02.020openalex-extracted
Patient-reported Outcome Measures in Metastatic Urinary Cancers
inferredcites →https://doi.org/10.1016/j.euo.2023.03.011openalex-extracted
Health-related Quality of Life and Cost Effectiveness of Treatment: Components to Be Included in Clinical Decision-making
inferredcites →https://doi.org/10.1016/j.eururo.2013.10.017openalex-extracted
Patient-reported Outcomes in Randomised Controlled Trials of Prostate Cancer: Methodological Quality and Impact on Clinical Decision Making
inferredcites →https://doi.org/10.1016/j.eururo.2017.03.037openalex-extracted
Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025
inferredcites →https://doi.org/10.1016/j.eururo.2017.11.016openalex-extracted
Updated European Association of Urology Guidelines: Recommendations for the Treatment of First-line Metastatic Clear Cell Renal Cancer
inferredcites →https://doi.org/10.1016/j.semnephrol.2019.12.009openalex-extracted
Immune Checkpoint Inhibitors in the Treatment of Renal Cell Carcinoma
inferredcites →https://doi.org/10.1016/s0140-6736(13)62229-1openalex-extracted
How to increase value and reduce waste when research priorities are set
inferredcites →https://doi.org/10.1016/s1470-2045(16)30510-1openalex-extracted
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards
inferredcites →https://doi.org/10.1016/s1470-2045(18)30418-2openalex-extracted
Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review
inferredcites →https://doi.org/10.1016/s1470-2045(19)30335-3openalex-extracted
US Food and Drug Administration review of statistical analysis of patient-reported outcomes in lung cancer clinical trials approved between January, 2008, and December, 2017
inferredcites →https://doi.org/10.1016/s1470-2045(19)30656-4openalex-extracted
Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review
inferredcites →https://doi.org/10.1016/s1474-4422(19)30357-6openalex-extracted
Patient-reported outcomes in the spotlight
inferredcites →https://doi.org/10.1038/s41585-023-00747-wopenalex-extracted
Patient-reported outcomes in metastatic renal cell carcinoma trials using combinations versus sunitinib as first-line treatment
inferredcites →https://doi.org/10.1038/s41585-023-00765-8openalex-extracted
Patient preferences in the treatment of genitourinary cancers
inferredcites →https://doi.org/10.1056/nejmp1114649openalex-extracted
Toward Patient-Centered Drug Development in Oncology
inferredcites →https://doi.org/10.1093/annonc/mdu489openalex-extracted
Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy
inferredcites →https://doi.org/10.1093/jnci/djaa174openalex-extracted
Patient-Reported Outcomes in Clinical Trials Leading to Cancer Immunotherapy Drug Approvals From 2011 to 2018: A Systematic Review
inferredcites →https://doi.org/10.1093/jnci/djz038openalex-extracted
Systematic Evaluation of Patient-Reported Outcome Protocol Content and Reporting in Cancer Trials
inferredcites →https://doi.org/10.1097/cco.0000000000000064openalex-extracted
Targeted therapies in urothelial carcinoma
inferredcites →https://doi.org/10.1097/ppo.0000000000000604openalex-extracted
Current State of Cell Therapies for Genitourinary Malignancies
inferredcites →https://doi.org/10.1186/s12885-016-2152-1openalex-extracted
Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review
inferredcites →https://doi.org/10.1186/s12894-019-0518-9openalex-extracted
Patient-reported outcomes in randomised clinical trials of bladder cancer: an updated systematic review
inferredcites →https://doi.org/10.1186/s13045-019-0780-zopenalex-extracted
Emerging therapeutic agents for genitourinary cancers
inferredcites →https://doi.org/10.1186/s40900-018-0092-4openalex-extracted
Patient led PROMs must take centre stage in cancer research
inferredcites →https://doi.org/10.1371/journal.pone.0076625openalex-extracted
Inconsistencies in Quality of Life Data Collection in Clinical Trials: A Potential Source of Bias? Interviews with Research Nurses and Trialists
inferredcites →https://doi.org/10.6004/jnccn.2020.0011openalex-extracted
Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.